| Pleotropic effects of polyphenols in cardiovascular system T Behl, S Bungau, K Kumar, G Zengin, F Khan, A Kumar, R Kaur, ... Biomedicine & Pharmacotherapy 130, 110714, 2020 | 181 | 2020 |
| Recognizing the benefits of pre-/probiotics in metabolic syndrome and type 2 diabetes mellitus considering the influence of akkermansia muciniphila as a key gut bacterium RA Corb Aron, A Abid, CM Vesa, AC Nechifor, T Behl, TC Ghitea, ... Microorganisms 9 (3), 618, 2021 | 149 | 2021 |
| Oxidative stress–Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders D Rotariu, EE Babes, DM Tit, M Moisi, C Bustea, M Stoicescu, AF Radu, ... Biomedicine & Pharmacotherapy 152, 113238, 2022 | 141 | 2022 |
| Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors CM Vesa, L Popa, AR Popa, M Rus, AA Zaha, S Bungau, DM Tit, ... Diagnostics 10 (5), 314, 2020 | 99 | 2020 |
| Early diagnosis of pancreatic cancer: the key for survival G Gheorghe, S Bungau, M Ilie, T Behl, CM Vesa, C Brisc, N Bacalbasa, ... Diagnostics 10 (11), 869, 2020 | 83 | 2020 |
| The non-invasive assessment of hepatic fibrosis G Gheorghe, S Bungău, G Ceobanu, M Ilie, N Bacalbaşa, OG Bratu, ... Journal of the Formosan Medical Association 120 (2), 794-803, 2021 | 77 | 2021 |
| Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options A Bondar, AR Popa, N Papanas, M Popoviciu, CM Vesa, M Sabau, ... Experimental and therapeutic medicine 22 (1), 1-9, 2021 | 76 | 2021 |
| What antibiotics for what pathogens? The sensitivity spectrum of isolated strains in an intensive care unit DC Zaha, S Bungau, S Aleya, DM Tit, CM Vesa, AR Popa, C Pantis, ... Science of the total environment 687, 118-127, 2019 | 69 | 2019 |
| Therapeutic approaches in the management of knee osteoarthritis B Uivaraseanu, CM Vesa, DM Tit, A Abid, O Maghiar, TA Maghiar, ... Experimental and therapeutic medicine 23 (5), 1-6, 2022 | 64 | 2022 |
| Withaferin A—A promising phytochemical compound with multiple results in dermatological diseases S Bungau, CM Vesa, A Abid, T Behl, DM Tit, AL Purza, B Pasca, ... Molecules 26 (9), 2407, 2021 | 59 | 2021 |
| Highlighting the relevance of gut microbiota manipulation in inflammatory bowel disease FM Pavel, CM Vesa, G Gheorghe, CC Diaconu, M Stoicescu, ... Diagnostics 11 (6), 1090, 2021 | 57 | 2021 |
| Risk factors for adiposity in the urban population and influence on the prevalence of overweight and obesity A Remus Popa, O Fratila, M Rus, R Anca Corb Aron, C Mihai Vesa, ... Experimental and therapeutic medicine 20 (1), 129-133, 2020 | 55 | 2020 |
| Recent Advances in Investigation, Prevention, and Management of Healthcare‐Associated Infections (HAIs): Resistant Multidrug Strain Colonization and Its Risk Factors in an … DC Zaha, R Kiss, C Hegedűs, R Gesztelyi, M Bombicz, M Muresan, ... BioMed research international 2019 (1), 2510875, 2019 | 51 | 2019 |
| Reviewing the Traditional/Modern Uses, Phytochemistry, Essential Oils/Extracts and Pharmacology of Embelia ribes Burm. V Sharma, DNS Gautam, AF Radu, T Behl, SG Bungau, CM Vesa Antioxidants 11 (7), 1359, 2022 | 50 | 2022 |
| Non-alcoholic fatty liver disease and cardiovascular comorbidities: pathophysiological links, diagnosis, and therapeutic management A Jichitu, S Bungau, AMA Stanescu, CM Vesa, MM Toma, C Bustea, ... Diagnostics 11 (4), 689, 2021 | 48 | 2021 |
| Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD S Bungau, T Behl, DM Tit, F Banica, OG Bratu, CC Diaconu, ... Experimental and therapeutic medicine 20 (6), 197, 2020 | 48 | 2020 |
| No-reflow after PPCI—A predictor of short-term outcomes in STEMI patients LR Pantea-Roșan, VA Pantea, S Bungau, DM Tit, T Behl, CM Vesa, ... Journal of clinical medicine 9 (9), 2956, 2020 | 46 | 2020 |
| Comorbidities, associated diseases, and risk assessment in COVID‐19—a systematic review A Fitero, SG Bungau, DM Tit, L Endres, SA Khan, AF Bungau, I Romanul, ... International Journal of Clinical Practice 2022 (1), 1571826, 2022 | 43 | 2022 |
| Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome D Carmen Zaha, C Vesa, D Uivarosan, O Bratu, O Fratila, D Mirela Tit, ... Experimental and therapeutic medicine 20 (1), 121-128, 2020 | 39 | 2020 |
| Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir PA Negru, AF Radu, CM Vesa, T Behl, MM Abdel-Daim, AC Nechifor, ... Biomedicine & Pharmacotherapy 147, 112700, 2022 | 38 | 2022 |
Simona BungauProfessor Habil. PhD., University of OradeaEmail verificata su uoradea.ro